William Byars
Impact in
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Pharmacology top 5%
- Pharmacology and Obesity Treatment
Papers in
-
- Bacterial Infections and Vaccines 3
-
- Diabetes Treatment and Management 1
William Byars
6 papers receiving 779 citations
William Byars's Hit Papers
Peers
Comparison fields: 5 of 64
- Endocrinology, Diabetes and Metabolism 463
- Pharmacology 300
- Physiology 185
- Endocrine and Autonomic Systems 38
- Pharmacy 25
Countries citing papers authored by William Byars
This map shows the geographic impact of William Byars's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Byars with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Byars more than expected).
Fields of papers citing papers by William Byars
This network shows the impact of papers produced by William Byars. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Byars. The network helps show where William Byars may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial Hit paper breakdown → | 2017 | 653 |
| 2 | RNA Interference With Zilebesiran for Mild to Moderate Hypertension Hit paper breakdown → | 2024 | 85 |
| 3 | 2018 | 73 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 2 |
About William Byars
William Byars is a scholar working on Microbiology, Endocrinology, Diabetes and Metabolism, Pharmacology, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 6 papers that have together received 824 indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (3 papers), Renin-Angiotensin System Studies (1 paper), Pharmacology and Obesity Treatment (1 paper), Diabetes Treatment and Management (1 paper), Respiratory viral infections research (1 paper) and Pneumonia and Respiratory Infections (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (463 citations), Pharmacology (300 citations), Physiology (185 citations), Endocrine and Autonomic Systems (38 citations) and Pharmacy (25 citations). William Byars has collaborated with scholars based in United States, Australia and Finland. Their work appears in journals such as The Lancet, JAMA, The Lancet Infectious Diseases, Open Forum Infectious Diseases and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.